113 studies found for:    30607
Show Display Options
Rank Status Study
1 Active, not recruiting Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Conditions: Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: sunitinib malate;   Other: placebo;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
2 Active, not recruiting
Has Results
An Open-label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine + Lapatinib in Patients With HER2-positive Locally Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Trastuzumab emtansine [Kadcyla];   Drug: Lapatinib;   Drug: Capecitabine
3 Active, not recruiting S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: fulvestrant
4 Completed Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
Condition: Urinary Bladder Neoplasms
Interventions: Drug: larotaxel (XRP9881);   Drug: gemcitabine;   Drug: cisplatin
5 Recruiting STEAM: A Study of Sequential and Concurrent FOLFOXIRI/Avastin (Bevacizumab) Regimens Versus FOLFOX/Avastin in First-Line in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: 5-fluorouracil;   Drug: bevacizumab [Avastin];   Drug: capecitabine [Xeloda];   Drug: fluoropyrimidine-based chemotherapy;   Drug: irinotecan;   Drug: leucovorin;   Drug: oxaliplatin
6 Terminated Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
Condition: Follicular Lymphoma
Interventions: Drug: Zevalin;   Drug: Rituximab
7 Recruiting Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO
Condition: Non Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dacomitinib Plus Blinded Doxycycline or Placebo;   Drug: Dacomitinib Plus Probiotic Plus Topical Alclometasone cream;   Drug: Dacomitinib
8 Recruiting Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Condition: Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Drug: Deferasirox placebo
9 Active, not recruiting Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Conditions: Breast Cancer;   Fatigue;   Hypothyroidism
Interventions: Other: physiologic testing;   Procedure: fatigue assessment and management;   Procedure: management of therapy complications
10 Recruiting A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
Condition: Metastatic Breast Cancer HR+, HER2-
Interventions: Drug: Fulvestrant;   Drug: BKM120;   Drug: BKM120 matching placebo
11 Completed
Has Results
Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer
Conditions: Recurrent Small-cell Lung Cancer (SCLC);   Lung Cancer, Small Cell
Intervention: Drug: Oral Hycamtin (topotecan) Capsules + IV Avastin (bevacizumab)
12 Completed Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma
Interventions: Drug: erlotinib hydrochloride;   Radiation: 3-dimensional conformal radiation therapy;   Drug: temozolomide
13 Completed A Study for Patients With Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: LY2603618;   Drug: Gemcitabine
14 Recruiting LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: LDK378;   Drug: pemetrexed;   Drug: docetaxel
15 Suspended S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Biological: cetuximab;   Drug: carboplatin;   Drug: paclitaxel
16 Terminated Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
Condition: HER-2 Positive Breast Cancer
Interventions: Drug: eribulin;   Drug: carboplatin;   Drug: trastuzumab
17 Recruiting A Study of LY2875358 in Non Small Cell Lung Cancer (NSCLC) Participants
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: LY2875358;   Drug: Erlotinib
18 Completed
Has Results
Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: capecitabine;   Drug: fulvestrant
19 Terminated Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung;   Lung Cancer;   Neoplasms, Lung;   Neoplasms, Pulmonary
Interventions: Drug: talabostat;   Drug: pemetrexed
20 Completed Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: pemetrexed disodium

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years